Phase II and pharmacokinetic study of fotemustine in inoperable colorectal cancer-Reference-Cited by-同舟云学术

Phase II and pharmacokinetic study of fotemustine in inoperable colorectal cancer

Published:1993-01 Issue:2 Volume:29 Page:288-289
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Rougier Philippe,Chabot Guy G.,Bonneterre Jacques,Tigaud Jean-Marie,Lucas Catherine,Baud Mariette,Bérille Jocelyne,Gouyette Alain

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference8 articles.

1. Final report of the French multicenter phase II study of the nitrosourea Fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases;Jacquillat;Cancer,1990

2. A new method for the measurement of nitrosoureas in plasma: an HPLC procedure for the measurement of fotemustine kinetics;Gordon;Xenobiotica,1989

3. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma;Poon;J Clin Oncol,1989

4. Phase II trial of fotemustine in advanced colorectal cancer;Bleiberg;Eur J Cancer,1990

5. Justification for evaluating new anticancer drugs in selected untreated patients with a chemotherapy-sensitive advanced cancer: an ECOG randomized study;Ettinger,1990

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alkylating and Platinating Agents;Current Cancer Therapeutics;2001

2. Phase I pharmacological study of intra-arterially infused fotemustine for colorectal liver metastases;European Journal of Cancer;1998-01

3. Fotemustine in patients with advanced gastric cancer, a phase II trial from the EORTC-GITCCG (European organization for research and treatment of cancer, gastrointestinal tract cancer cooperative group);European Journal of Cancer;1996-07